Intra-arterial chemotherapy in retinoblastoma – A paradigm change
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment modalities for intraocular retinoblastoma worldwide. Following the introduction of the technique in 1998, IAC has evolved over...
Main Authors: | Fairooz P Manjandavida, Christina Stathopoulos, Jing Zhang, Santhosh G Honavar, Carol L Shields |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=6;spage=740;epage=754;aulast=Manjandavida |
Similar Items
-
The middle meningeal artery as an alternative route for intra-arterial chemotherapy
by: Mario Zanaty, et al.
Published: (2015-06-01) -
Sclero-conjunctival ischaemia secondary to intra-arterial chemotherapy for retinoblastoma
by: Lisa McAnena, et al.
Published: (2020-06-01) -
Ophthalmic artery chemosurgery: A nursing perspective
by: Mary Elizabeth Davis, et al.
Published: (2017-01-01) -
Intra-arterial chemotherapy for retinoblastoma: Our first experience in Indonesia
by: Prijo Sidipratomo, MD, PhD, et al.
Published: (2022-12-01) -
Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma
by: Namita Kumari, et al.
Published: (2023-01-01)